Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax ( hin a few days some spores can remain ...)

Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax

hin a few days, some spores can remain dormant for much longer periods, which poses special challenges with regard to postexposure treatment. According to Friedlander, antibiotics are active only after spores have germinated; therefore, dormant spores that germinate after therapy has been discontinued can cause disease and death. This delayed germination necessitates prolonged use of antibiotics after an inhalational exposure.

Animal experiments have confirmed the prolonged persistence of spores and incubation period after aerosol exposure. In one study, rhesus macaques were protected during a 30-day course of antibiotics after aerosol exposure. However, some animals developed fatal infection after the antibiotic therapy was discontinued.

"In spite of the low compliance rates we saw in 2001--where more than half of the people did not take the full 60-day course--there were no additional anthrax cases," Friedlander commented. "This suggests that the doses of inhaled spores were probably very low. In contrast, computer modeling suggests that protection against higher doses of anthrax spores could require that antibiotics be continued for as long as four months. Adding vaccine to a postexposure regimen of antibiotics may shorten the duration and thus avoid the problems of noncompliance associated with a prolonged course."

Colonel George W. Korch, Jr., USAMRIID commander, added, "The tremendous value of interagency collaboration cannot be understated in this very important finding, which stands to potentially improve the course of therapeutic intervention, as well as enhance overall protection against this significant biological threat."

Source:US Army Medical Research Institute of Infectious Diseases

Page: 1 2 3
Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. Live Recombinant Adenovirus Vaccine Technique Explored
3. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
4. NIAID Initiates Trial of Experimental Avian Flu Vaccine
5. Study Models Impact Of Anthrax Vaccine
6. New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines
7. Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy
8. EuroVacc 02 HIV Vaccine Trial Begins
9. Active Vaccine Prevents Mice From Developing Prion Disease
10. New Vaccine To Be Used For First Time In Polio Outbreak Response
11. Boosting The BCG Vaccine To Beat Tuberculosis

Post Your Comments:

(Date:12/16/2009)... source of financial and technical assistance to developing countries ... appear to be connected to space technology, but large ... intrinsically linked. , Global climate change is also an ... in the poorest countries and communities, which will suffer ... led to a growing demand for information about the ...

(Date:12/16/2009)... than 4 billion years before humans showed up, and ... That suggests they may have something to teach us. ... Prof. Eshel Ben-Jacob of the Raymond and Beverly Sackler ... of bacteria, presents compelling evidence to suggest there may ... opt for the swine flu H1N1 shot. , In ...

(Date:12/16/2009)... SUNNYVALE, Calif., Dec. 1 GestureTek ... CUBE, Release 3.0 - a turnkey, portable, ... for advertising, exhibits, entertainment and touring promotions. ... dozens of patents in camera-enabled gesture recognition ... systems. ,, Guaranteed for quality, the CUBE ...

Breaking Biology News(10 mins):ESA and World Bank move toward closer collaboration 2 ESA and World Bank move toward closer collaboration 3 ESA and World Bank move toward closer collaboration 4 Bacteria wouldn't opt for a swine flu shot 2 Bacteria wouldn't opt for a swine flu shot 3 GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2 GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 1 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 2 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 3 Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 1 Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 2 Oncolytics Biotech 28R 29 Inc Completes Lyophilization Process for REOLYSIN 28R 29 13083 1 Oncolytics Biotech 28R 29 Inc Completes Lyophilization Process for REOLYSIN 28R 29 13083 2

[0] ESA and World Bank move toward closer collaboration [0] Bacteria wouldn't opt for a swine flu shot [0] GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits

... marine biologists will gather in Auckland from 14-16 November to ... to the tropics. This major meeting of a global marine ... jointly hosted by the National Institute of Water & Atmospheric ... The Census of Marine Life is a ten-year initiative to ...

... confused feelings that occur when you meet someone whose ... his or her gender., A new study by neuroscientists ... processing of such sensory information about anothers gender to ... study concludes that it does, weighing in with findings ...

... There are many historical stories of shepherds and travellers ... of tales about attacks on flocks and people by ... of their former range, but for livestock owners around ... a daily reality. Although loss of human life is ...

Other Biology News:Hearing changes how we perceive gender 2 Hearing changes how we perceive gender 3 Hearing changes how we perceive gender 4 Living with lions 2

Scientists gather in New Zealand to share oceans' secrets Hearing changes how we perceive gender Living with lions

(Date:12/16/2009)... 22% for fiscal 2009; on track for positive ... 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a ... today reported financial results for fourth quarter and ... 30, 2009, Microbix reported revenues of $6.08 million, ... 2008. For fourth-quarter 2009, the Company saw revenues ...

(Date:12/16/2009)... LLC introduces HSP-A Soy Peptone. HSP A has been found ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( ... HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, ... to improve growth rates and yields. HSP-A has been found ...

(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...

(Date:12/15/2009)... PLYMOUTH, Minn., Dec. 15 The Mosaic Company (NYSE: ... quarter fiscal year 2010 earnings results and financial tables ... trading on the New York Stock Exchange. Results ... ,, The Company will host a conference call ... discuss the results. The call will begin at ...

Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2 Microbix' Pipeline Set To Reach Milestones In 2010 3 Microbix' Pipeline Set To Reach Milestones In 2010 4 Microbix' Pipeline Set To Reach Milestones In 2010 5 Microbix' Pipeline Set To Reach Milestones In 2010 6 Microbix' Pipeline Set To Reach Milestones In 2010 7 Microbix' Pipeline Set To Reach Milestones In 2010 8 China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2 China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3 Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2

[0] Microbix' Pipeline Set To Reach Milestones In 2010 [0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call

... July 25 Beckman,Coulter, Inc. (NYSE: BEC ... that simplify, automate and innovate complex biomedical,testing, announced ... 30, 2008,results. Total revenue of $798.3 million increased ... was up 11.2%. Net earnings were,$47.8 million, or ...

... Mind Foundation and conducted by TNS Teleseker, revealed that a majority ... methods that could "put them into a creative state and keep ... ... Jerusalem, Israel (PRWEB) July 26, 2008 -- A recent ...

... and SAN DIEGO, July 24 /PRNewswire-FirstCall/ - MIGENIX ... drugs for infectious,diseases, advises that the directors of ... (the "Meeting") to be held at 2:00 p.m. ... 2389 Health Sciences Mall, Vancouver,British Columbia. Further details ...

Beckman Coulter Announces Second Quarter 2008 Results Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science Notice of MIGENIX General Meeting of Shareholders

... Vesicular Monoamine Transporter 2 (VMAT2). An antibody ... a major band at ~55 kDa in ... and not in wild type cells (2). ... molecular weight, were also detected and remain ...

... INK4a-ARF locus encodes two unrelated proteins both ... arrests the cell cycle in a p53-dependent ... the rapid degradation of mdm2 proteinrequired for ... accumulation. This interaction is mediated by ...

... immunoblotting the antibody reacts against the reduced ... MMP-2 or MMP-2 bound to TIMP-2. affinity ... Solution in 0.01 M phosphate buffered ... 15 mM sodium azide. synthetic peptide corresponding ...

... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...

Biology Products:

Anti-Vesicular Monoamine Transporter 2 (VMAT2) Polyclonal Antibody, Unconjugated from CHEMICON Mouse Anti-p14 ARF / p16Beta Ab-2 Mouse Monoclonal Antibody, Unconjugated, Clone 14P02 from Lab Vision Rabbit Anti-Matrix Metalloproteinase-2, Hinge Region Antibody, Unconjugated from Sigma-Aldrich Corning Culture Flask, 150 cm2, Tc-Treated, Angled Neck, Phenolic-Style, Sterile from Sigma-Aldrich

( hin a few days some spores can remain ...)Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax